Andrew Galligan — Chief Financial Officer at Nevro

Mr. Andrew H. Galligan has been the Chief Financial Officer at Nevro Corp. since May 2010 and served as its Vice President of Finance since May 2010. Mr. Galligan served as the Chief Financial Officer of ooma Inc. from February 2009 to May 2010. He served as the Chief Financial Officer and Vice President of Finance at Reliant Technologies, Inc. from July 2007 to 2008. He has over twenty years of extensive experience in leading the finance activities of public companies, including directing initial public offerings. From January 2007 to July 2007, Mr. Galligan served as a Consultant of Reliant Technologies, Inc. From March 2003 to January 2007, he served as Vice President and Chief Financial Officer of Metrika, Inc. He joined Corcept Therapeutics Inc. in November 2001 and served as its Chief Financial Officer from November 2001 to March 2003 and also its Vice President of Finance and Principal Accounting Officer. From 1998 to 2001, Mr. Galligan served as Vice President of Finance and Chief Financial Officer at Amira Medical Inc. From December 1993 to June 1998, he served as a Vice President of Finance and Chief Financial Officer of Molecular Devices Corporation. From 1992 to 1993, he served as Vice President of Finance and Chief Financial Officer at IPS Health Care, Inc. and Lumisys, Inc. Mr. Galligan served as Vice President of Finance at Diasonics, Inc. He has been Director of ooma Inc since December 2014. He served as a Director at Diadexus, Inc. since November 4, 2010 until January 2015. He served as a Director of Metrika, Inc. He is a Fellow of the Institute of Chartered Accountants in Ireland. He received his Degree in Business Studies from Trinity College in Dublin, Ireland.